Transcend Biologics appointed Barry Dull as President of Sales to lead growth, business development, and clinician partnerships in regenerative biologics.
Transcend Biologics, a leading provider of innovative Platelet-Rich Plasma (PRP) and regenerative medicine solutions, announced the appointment of Barry Dull as President of Sales. He is a seasoned executive with more than 20 years of experience driving sales strategy and organizational growth across multiple industries, will lead Transcend Biologics’ national sales, business development, and customer success initiatives.
Barry joins Transcend Biologics as an accomplished, results-driven leader with a track record of success spanning Energy (Oil & Gas, Chemicals), Manufacturing, IT Services and Technology, Lumber, and Healthcare. Recognized for his integrity, creativity, and growth-oriented leadership, he has consistently built high-performing teams, cultivated lasting strategic partnerships, and delivered measurable value to customers.
Barry’s leadership, integrity, and vision make him an exceptional addition to our team, strengthening partnerships and advancing our mission to deliver innovative regenerative solutions.”
— Paul O’Brien, Co-Founder and CEO, Transcend Biologics
Marketing Technology News: MarTech Interview with Julian Highley, EVP, Global Data Science & Product @ MarketCast
As President of Sales, Barry will oversee national sales strategy and market expansion, working closely with the executive team to strengthen relationships with clinicians and empower the sales organization to deliver exceptional service to healthcare professionals utilizing Transcend’s regenerative technologies.
Barry joins Transcend from Davis-Hawn Lumber Co. & Architectural Millworks, where he developed a strong foundation in client relations and solution-based sales, skills that will be instrumental in his new leadership role. He holds a Bachelor of Science in Petroleum Engineering from the University of Kansas and an MBA from Texas Christian University’s M.J. Neeley School of Business. Barry brings a combination of technical expertise and relational leadership that has fueled consistent revenue growth and operational excellence across diverse industries.
Barry will represent Transcend Biologics, the exclusive U.S. distributor of TropoVet®, at the upcoming 71st AAEP Annual Convention, December 6–10, 2025, in Denver, Colorado. TropoVet®, a leading line of regenerative veterinary therapies, including PRP, PRF, IRAP, and Gel Treatment systems, are engineered to promote natural healing across species. Designed for simplicity, reliability, and measurable results, TropoVet® powered by Transcend Biologics provides veterinarians with evidence-based biologic solutions that accelerate healing, restore function, and advance the science of regenerative medicine in animal care.
The Transcend Biologics team will also host a special presentation by Dr. Gili Schvartz, VDM, PhD, R&D Manager at Estar Medical.
“Barry’s leadership, integrity, and vision for growth make him an exceptional addition to our executive team,” said Paul O’Brien, Co-Founder and CEO of Transcend Biologics. “His experience and relationship-driven approach will strengthen customer partnerships and advance our mission to deliver innovative, evidence-based regenerative solutions that improve patient outcomes.”
Beyond his professional accomplishments, Barry is deeply committed to mentorship and community service. He has volunteered with Athletes in Action, FC Dallas, Dallas Cowboys Outreach, and West Dallas Outreach, and has served on the Board of Directors for OK Mozart. His dedication to service and leadership reflects a life guided by excellence, integrity, and purpose, values that align closely with Transcend Biologics’ mission to improve lives through innovation.
Marketing Technology News: Martech & the ‘Digital Unconscious’: Unearthing Hidden Consumer Motivations
